Bank of America’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bank of America’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200	Closed	-$5K	–	7899
2020 Q4	$5K	Buy	+200	New	+$6.63K	﹤0.01%	6834
2020 Q2	–	Sell	-33,300	Closed	-$2.1M	–	7219
2020 Q1	$2.1M	Buy	+33,300	New	+$2.99M	﹤0.01%	3443
2018 Q1	–	Sell	-4,900	Closed	-$286K	–	7410
2017 Q4	$286K	Buy	+4,900	New	+$309K	﹤0.01%	5249
2017 Q2	–	Sell	-15,900	Closed	-$1.8M	–	7245
2017 Q1	$1.8M	Buy	+15,900	New	+$1.86M	﹤0.01%	3963
2016 Q2	–	Sell	-4,000	Closed	-$514K	–	7464
2016 Q1	$514K	Buy	+4,000	New	+$472K	﹤0.01%	4583
2014 Q2	–	Sell	-500	Closed	-$165K	–	8267
2014 Q1	$165K	Buy	+500	New	+$169K	﹤0.01%	5594

Bank of America's ICPT Position: Q4 2023 in Review

Bank of America sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 402,359 shares — an estimated $7.46M sold.

Bank of America first reported a position in ICPT in Q2 2013 and held it in 42 quarters. The position peaked at $66.7M in Q3 2016. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Bank of America reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Bank of America sold 402,359 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $7.46M.
Bank of America first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 42 quarters.
Bank of America's Intercept Pharmaceuticals, Inc. position peaked at $66.7M in Q3 2016.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.